COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02157987
Brief Title: Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose (EROSB)

First Submitted : June 4, 2014
First Submitted that Met QC Criteria : June 4, 2014
First Posted : June 6, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 26, 2015
Last Update Posted : January 27, 2015 (Estimate)